Aurora Cardiovascular Services, Aurora St Luke's Medical Center, Milwaukee, WI, USA.
Department of Medicine, Medical College of Wisconsin, Milwaukee, USA.
BMC Cardiovasc Disord. 2020 Aug 14;20(1):367. doi: 10.1186/s12872-020-01620-z.
Subclinical diastolic dysfunction is a precursor for developing heart failure with preserved ejection fraction (HFpEF); yet not all patients progress to HFpEF. Our objective was to evaluate clinical and echocardiographic variables to identify patients who develop HFpEF.
Clinical, laboratory, and echocardiographic data were retrospectively collected for 81 patients without HF and 81 matched patients with HFpEF at the time of first documentation of subclinical diastolic dysfunction. Density-based clustering or hierarchical clustering to group patients was based on 65 total variables including 19 categorical and 46 numerical variables. Logistic regression analysis was conducted on the entire study population as well as each individual cluster to identify independent predictors of HFpEF.
Unsupervised clustering identified 3 subgroups which differed in gender composition, severity of cardiac hypertrophy and aortic stenosis, NT-proBNP, percentage of patients who progressed to HFpEF, and timing of disease progression from diastolic dysfunction to HFpEF to death. Clusters that had higher percentages of women had progressively milder cardiac hypertrophy, less severe aortic stenosis, lower NT-proBNP, were diagnosed at an older age with HFpEF, and survived to an older age. Independent predictors of HFpEF for the entire cohort included diabetes, chronic kidney disease, atrial fibrillation, and diuretic use, with additional predictive variables found for each cluster.
Cluster analysis can identify phenotypically distinct subgroups of patients with diastolic dysfunction. Clusters differ in HFpEF and mortality outcome. In addition, the variables that correlate with and predict HFpEF outcome differ among clusters.
亚临床舒张功能障碍是射血分数保留心力衰竭(HFpEF)发展的前兆;然而,并非所有患者都会进展为 HFpEF。我们的目的是评估临床和超声心动图变量,以确定发生 HFpEF 的患者。
回顾性收集 81 例无心力衰竭和 81 例亚临床舒张功能障碍首次记录时伴有 HFpEF 的患者的临床、实验室和超声心动图数据。基于包括 19 个分类变量和 46 个数值变量在内的 65 个总变量,采用密度聚类或层次聚类对患者进行分组。对整个研究人群以及每个单独的聚类进行逻辑回归分析,以确定 HFpEF 的独立预测因素。
无监督聚类确定了 3 个亚组,这些亚组在性别构成、心脏肥大和主动脉瓣狭窄的严重程度、NT-proBNP、进展为 HFpEF 的患者比例以及从舒张功能障碍进展为 HFpEF 至死亡的疾病进展时间方面存在差异。女性比例较高的聚类心脏肥大逐渐减轻、主动脉瓣狭窄较轻、NT-proBNP 较低、HFpEF 的诊断年龄较大、存活年龄较大。整个队列中 HFpEF 的独立预测因素包括糖尿病、慢性肾脏病、心房颤动和利尿剂使用,每个聚类都有额外的预测变量。
聚类分析可以识别出具有舒张功能障碍的表型不同的患者亚组。聚类在 HFpEF 和死亡率方面存在差异。此外,与 HFpEF 结果相关并预测 HFpEF 结果的变量在聚类之间存在差异。